Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cyteir Therapeutics, Inc. (CYT)  
$3.02 0.00 (0.00%) as of 4:30 Fri 3/15


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 35,370,000
Market Cap: 106.82(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.74 - $3.15
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cyteir Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing the oncology medicines that inhibit deoxyribonucleic acid damage repair and cause cancer cell death in specific subsets of cancer patients through a therapeutic strategy known as synthetic lethality. Co.'s primary program, CYT-0851, was identified through a phenotypic screening strategy that exploited a synthetic lethality between cytidine deaminases (CD) overexpression and homologous recombination inhibition. The screen was designed to select for compounds that induced synthetic lethality in CD-overexpressing cancer cells while sparing normal cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 284,366 284,366 284,366 366,717
Total Buy Value $845,707 $845,707 $845,707 $989,543
Total People Bought 1 1 1 3
Total Buy Transactions 2 2 2 7
Total Shares Sold 0 0 401,548 1,301,548
Total Sell Value $0 $0 $1,026,787 $3,726,787
Total People Sold 0 0 1 1
Total Sell Transactions 0 0 14 15
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 59
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Leonard Braden Michael   •       •       •   2024-03-20 4 B $2.95 $503,238 I/I 170,589 3,654,053 0.01     -
   Leonard Braden Michael   •       •       •   2024-03-18 4 B $3.01 $342,469 I/I 113,777 3,483,464 0.01     -
   Leonard Braden Michael   –       –       •   2024-03-15 3 IO $0.00 $0 D/D 0 335,000     -
   Leonard Braden Michael   –       –       •   2024-03-15 3 IO $0.00 $0 I/I 0 3,369,687     -
   Renschler Markus Md President and CEO   •       •      –    2024-03-04 4 OE $1.69 $10,654 D/D 6,304 1,103,661     -
   Gaiero David G Chief Financial Officer   •       –      –    2024-03-04 4 OE $1.69 $4,010 D/D 2,373 102,391     -
   Renschler Markus Md President and CEO   •       •      –    2024-02-29 4 OE $1.20 $24,350 D/D 15,144 1,097,357     -
   Gaiero David G Chief Financial Officer   •       –      –    2024-02-29 4 OE $1.68 $13,462 D/D 7,985 100,018     -
   George Jean Director   –       •      –    2024-02-14 4 OE $1.69 $23,914 D/D 14,150 14,150     -
   Sands Stephen H. Director   –       •      –    2024-02-09 4 OE $1.69 $20,498 D/D 12,129 12,129     -
   Thero John F Director   –       •      –    2024-02-08 4 OE $1.69 $21,679 D/D 12,828 22,828     -
   Zakrzewski Joseph S Director   –       •      –    2024-02-06 4 OE $1.69 $23,914 D/D 14,150 227,439     -
   Gaiero David G Chief Financial Officer   •       –      –    2023-12-11 4 OE $1.68 $6,732 D/D 3,993 92,033     -
   Renschler Markus Md President and CEO   •       •      –    2023-11-20 4 OE $1.20 $13,697 D/D 8,840 1,082,213     -
   Gaiero David G Chief Financial Officer   •       –      –    2023-11-20 4 OE $1.68 $124,433 D/D 73,940 88,040     -
   Renschler Markus Md President and CEO   •       •      –    2023-11-20 4 OE $1.20 $129,366 D/D 84,637 1,073,373     -
   Novo A/s 10% Owner   –       –       •   2023-07-20 4 S $2.75 $275,140 D/D (100,000) 3,522,136 -10%     
   Novo A/s 10% Owner   –       –       •   2023-07-19 4 S $2.76 $5,247 D/D (1,900) 3,622,136 -11%     
   Novo A/s 10% Owner   –       –       •   2023-07-18 4 S $2.76 $17,923 D/D (6,500) 3,624,036 -10%     
   Novo A/s 10% Owner   –       –       •   2023-07-17 4 S $2.75 $58,000 D/D (21,100) 3,630,536 -10%     
   Novo A/s 10% Owner   –       –       •   2023-07-14 4 S $2.74 $30,102 D/D (11,000) 3,651,636 -12%     
   Novo A/s 10% Owner   –       –       •   2023-06-30 4 S $2.63 $529,288 D/D (200,937) 3,662,636 -16%     
   Novo A/s 10% Owner   –       –       •   2023-06-27 4 S $1.77 $56,687 D/D (31,978) 3,863,573 -68%     
   Novo A/s 10% Owner   –       –       •   2023-06-26 4 S $1.79 $15,106 D/D (8,437) 3,895,551 -68%     
   Novo A/s 10% Owner   –       –       •   2023-06-23 4 S $1.88 $6,447 D/D (3,423) 3,903,988 -58%     
  59 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us